H2apex Group Sca · XETR:H2A
H2apex Group Sca — exceet Group SCA — Investor Presentation (January 2020)
27 slides from H2apex Group Sca's investor presentation, Jan 23, 2020
Slide 1: Company Presentation
Company Presentation January 2020
Slide 2: Overview, Activities, Financial Review & Analysis
§ Overview § Activities § Financial Review & Analysis January 2020 | Page 2
Slide 3: Our Profile
Our Profile Continued Basis exceet is a listed holding company pursuing an in EUR million FY 2017 FY 2018 9M 2018 9M 2019 opportunistic investment approach without a defined investment strategy. The investment Net Sales 42.4 41.5 31.1 32.7 focus is on seizing attractive risk / reward profiles withou
Slide 4: Our Current Segments
Our Current Segments Reporting Segments 1) Competences End Markets 1) Application Examples Healthcare Health Miniaturization § IoT § Hearing Aids 79% § Cochlea Implants § PKI Complexity § Cloud-Based § Implants Security 72% of group net sales § Telematics Services Software Infrastructure & Reliabili
Slide 5: Activities
§ Overview § Activities § Financial Review & Analysis January 2020 | Page 5
Slide 6: Current Activities
Current Activities Healthcare Software (including IoT) Net Sales: EUR 32.6 million / EBITDA: 25.4% Net Sales: EUR 9.0 million / EBITDA: (6.2%) ¡ Healthcare excels in manufacturing extremely ¡ Software activities are actually focused on secure reliable and highly miniaturized flex, rigid-flex and sol
Slide 7: Health - Implantable Cardioverter Defibrillator
Health - Implantable Cardioverter Defibrillator Development & Production of highly miniaturized, extremely durable PCBs 4-Layer Rigid-Flex Board by exceet Newest generation of Implantable Cardioverter Defibrillator Description Advantages for customers / users § exceet provides the PCB for a subcutan
Slide 8: Health - Cochlea Hearing Aids
Health - Cochlea Hearing Aids Development & Production of highly miniaturized, extremely durable PCBs Description Advantages for customers / users § Development and manufacturing of printed § Can be used already in infancy - enables circuit board (PCB) for implants participation in social life and p
Slide 9: Innovation – Ultra HDI Printed Circuit Boards
Innovation – Ultra HDI Printed Circuit Boards New market possibilities due to innovative technological progress Katheter Eye Sensors Ultra-Sonic X-Ray Description Advantages for customers / users § Very small features (line width and space down to 10µm/10µm and below) § Higher resolution with better
Slide 10: Industrial IoT - Secure Edge Computing
Industrial IoT - Secure Edge Computing The Power of Edge Computing with your own Apps near the device Edge Fog Cloud Pay per Use Predictive Data Storage Maintenance Description Advantages for customers / users § IoT Gateway with hardware based security § Managed IoT Stack for secure edge § Simple, s
Slide 11: Industrial IoT - exceet connect
Industrial IoT - exceet connect Secure, scalable & modular solution Secure Device Management Maximum secure management of industrial IoT devices by hardware based cryptography Data encryption in the cloud Managed Service for hardware based data encryption in the cloud & cloud applications Identity M
Slide 12: Industrial IoT - Devices for M2M Solutions
Industrial IoT - Devices for M2M Solutions Charging solutions for electric vehicles Remote service via VPN service portal Description Advantages for customers / users § Transparent remote service § Simple, safe and scalable solution for recharging electric cars § Automatic configuration of devices §
Slide 13: Industrial IoT - Devices for M2M Solutions
Industrial IoT - Devices for M2M Solutions Contour monitoring for transport containers and boxes for one of the largest automotive suppliers in Europe Description Advantages for customers / users § Light curtain system and analysis § Optimal and trouble-free transport § Contour check monitoring § He
Slide 14: Industrial IoT - Industrial Solutions
Industrial IoT - Industrial Solutions Intelligent & secure networking of machine tools Description Advantages for customers / users § Selection and realization of a costumer § Comprehensive, real-time machine tool specific pilot IoT Platform for networking of data available at different locations an
Slide 15: Financial Review & Analysis
§ Business Overview § Activities § Financial Review & Analysis January 2020 | Page 15
Slide 16: Financial Highlights
Financial Highlights 1) ▪ Free Cash Flow EUR 1.0 million • Revenues are up 5.2% to (9M 2018: EUR 0.6 million) driven by: EUR 32.7 million ▪ Operational Cash Flow EUR 4.4 million Net (9M 2018: EUR 31.1 million) Free (9M 2018: EUR 1.6 million) Sales Cash ▪ Organic growth: 2.2% ▪ Capex of EUR 3.4 milli
Slide 17: Net Sales & EBITDA
Net Sales & EBITDA 1) (in EUR 1’000) 690 933 Net Sales 31’115 31’805 32’738 Actual Organic growth Like for like FX Impact Scope changes Actual 9M 2018 9M 2019 630 122 802 EBITDA 5.117 3’563 4’193 4’315 Actual Organic growth Like for like FX Impact Scope changes Actual One-off Recurring 9M 2018 9M 20
Slide 18: From EBITDA to Free Cash Flow
From EBITDA to Free Cash Flow (in EUR 1’000) (951) 1’737 (81) (668) (3’355) 4.315 997 Reported EBITDA Non-cash items recorded Taxes paid Interest paid Change in NWC Net Capex Free Cash Flow 9M 2019 above EBITDA 9M 2019 ■ Free Cash Flow in 9M 2019 EUR 1.0 million versus EUR 0.6 million in 9M 2018 ■ M
Slide 19: Net Cash
Net Cash (in EUR 1’000) 997 (1’189) (131) (240) 109’398 108’835 Actual Free Cash Flow FX Impact FX Impact Others Actual YE 2018 on cash on borrowings 9M 2019 Borrowings (3'790) Borrowings (3'514) Cash 113'188 Cash 112'349 Net Cash 109'398 Net Cash 108'835 ■ Net Cash decreased in 9M 2019 by EUR 0.6 m
Slide 20: exceet is exciting
Lh ©XxXCeE|T is exciting
Slide 21: Annex
exceet Annex January 2020 | Page 21
Slide 22: Notified Shareholdings (23 January 2020)
Notified Shareholdings (23 January 2020) 1) Share Capital exceet Group SCA Ordinary shares (listed bearer shares 2)) 20'073'695 Unlimited share (registered share General Partner 3)) 1 Total shares exceet Group SCA 20'073'696 Issued Ordinary Shares 20'073'695 ordinary shares 100.0% Notified Sharehold
Slide 23: Consolidated Financials
Consolidated Financials January – September 2018 & 2019 Income Statement (in EUR 1'000) Jan. - Sep. 2019 Jan. - Sep. 2018 Revenue 32'738 31'115 Cost of sales (24'888) (24'065) Gross profit 7'850 7'050 % margin 24.0% 22.7% Distribution costs (2'419) (2'515) Administrative expenses (3'500) (3'106) Oth
Slide 24: Consolidated Financials
Consolidated Financials 31 December 2018 / 30 September 2019 Assets (in EUR 1'000) 30 September 2019 31 December 2018 Tangible assets 10'054 9'295 Right-of-use assets 1) 2'913 0 Intangible assets 10'520 10'843 Deferred tax assets 1'341 599 Inventories 3'848 3'872 Trade receivables, net 5'395 3'458 C
Slide 25: Consolidated Financials
Consolidated Financials January – September 2018 & 2019 Cash Flow Statement (in EUR 1'000) Jan. - Sep. 2019 Jan. - Sep. 2018 1) Earnings before taxes 2'394 1'462 Depreciation, amortization & impairment charges 2'285 2'403 Financial income / (expenses), net 91 (987) Change of provisions 480 0 Other n
Slide 26: Consolidated Financials
Consolidated Financials January – September 2018 & 2019 Segment Information Healthcare Software Corporate & Eliminations Group (incl. IoT) Others Consolidation Jan. - Sep. Jan. - Sep. Jan. - Sep. Jan. - Sep. Jan. - Sep. (in EUR 1'000) 2019 2018 2019 2018 2019 2018 2019 2018 2019 2018 Net Sales 25'96
Slide 27: Disclaimer & Contact
Disclaimer & Contact This presentation contains forward-looking statements based on beliefs of exceet Group SCA management. Such statements reflect current views of exceet Group SCA with respect to future events and results and are subject to risks and uncertainties. Actual results may vary material
exceet Group SCA — Investor Presentation (January 2020) on 6ix